{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:11:35Z","timestamp":1784945495619,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Vogt\u2013Koyanagi\u2013Harada syndrome (VKH) is a rare autoimmune condition affecting melanocyte-containing tissues such as the eyes, skin, hair, inner ear, and meninges. The disease progresses through four phases: prodromal, uveitic, convalescent, and recurrent. Symptoms include headaches, photophobia, ocular inflammation, and auditory disturbances. Although the etiology behind VKH is unknown, it is believed to be triggered by viral infections such as the Epstein\u2012Barr virus or Cytomegalovirus in genetically predisposed individuals. It is diagnosed by confirming bilateral ocular involvement and ruling out other conditions, such as tuberculosis. It is managed by corticosteroids, with steroid pulse therapy being effective for controlling inflammation and improving outcomes. However, it carries significant risks, such as hypertension, infections, and electrolyte imbalances. Managing VKH during pregnancy can be challenging and requires a multidisciplinary approach, as corticosteroid use can affect both maternal and fetal health. Steroid therapy is crucial for controlling disease, but it can lead to complications such as infections, fetal growth restriction, and potential neurodevelopmental issues in infants. Future research should focus on optimizing steroid regimens, understanding the long-term effects of corticosteroid use during pregnancy, and developing personalized treatment strategies to improve maternal and fetal outcomes in VKH management.<\/jats:p>","DOI":"10.1186\/s13023-025-03916-9","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T09:20:05Z","timestamp":1752657605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Steroid pulse therapy for VKH during pregnancy: a safe and effective option?"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6488-4172","authenticated-orcid":false,"given":"Umashri","family":"Sundararaju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0260-7801","authenticated-orcid":false,"given":"Shanmathi","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9642-9915","authenticated-orcid":false,"given":"Hamrish Kumar","family":"Rajakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"3916_CR1","doi-asserted-by":"publisher","unstructured":"Patil YB, Garg R, Rajguru JP, Sirsalmath M, Bevinakatti VA, Kumar M et al. Vogt\u2013Koyanagi\u2013Harada (VKH) syndrome: A new perspective for healthcare professionals. J Family Med Prim Care [Internet]. 2020;9(1):31\u20135. Available from: https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_787_19","DOI":"10.4103\/jfmpc.jfmpc_787_19"},{"key":"3916_CR2","doi-asserted-by":"publisher","unstructured":"Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt\u2013Koyanagi\u2013Harada disease. Br J Ophthalmol [Internet]. 1996;80(11):1002\u20138. Available from: https:\/\/doi.org\/10.1136\/bjo.80.11.1002","DOI":"10.1136\/bjo.80.11.1002"},{"key":"3916_CR3","doi-asserted-by":"publisher","unstructured":"Mochizuki M. Regional immunity of the eye. Acta Ophthalmol [Internet]. 2009;88(3):292\u20139. Available from: https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01757.x","DOI":"10.1111\/j.1755-3768.2009.01757.x"},{"key":"3916_CR4","volume-title":"Vogt\u2013Koyanagi\u2013Harada syndrome","author":"EM Stern","year":"2024","unstructured":"Stern EM, Nataneli N. In: StatPearls, editor. Vogt\u2013Koyanagi\u2013Harada syndrome. Treasure Island (FL): StatPearls Publishing; 2024."},{"key":"3916_CR5","doi-asserted-by":"crossref","unstructured":"Herbort CP Jr, Tugal-Tutkun I, Abu-El-Asrar A, Gupta A, Takeuchi M, Fardeau C et al. Precise, simplified diagnostic criteria and optimized management of initial-onset Vogt\u2013Koyanagi\u2013Harada disease: an updated review. EYE [Internet]. 2022 [cited 2024 Sep 17];36(1):29\u201343. Available from: https:\/\/www.nature.com\/articles\/s41433-021-01573-3","DOI":"10.1038\/s41433-021-01573-3"},{"key":"3916_CR6","unstructured":"Vogt-koyanagi-Harada disease. Comparison of first-line treatments [Internet]. American Academy of Ophthalmology. 2024 [cited 2025 Feb 14]. Available from: https:\/\/www.aao.org\/eyenet\/article\/vogt-koyanagi-harada-disease-treatments"},{"key":"3916_CR7","doi-asserted-by":"publisher","unstructured":"Sinha A, Bagga A. Pulse steroid therapy. Indian J Pediatr [Internet]. 2008;75(10):1057\u201366. Available from: https:\/\/doi.org\/10.1007\/s12098-008-0210-7","DOI":"10.1007\/s12098-008-0210-7"},{"key":"3916_CR8","doi-asserted-by":"publisher","unstructured":"Mustafi S, Sinha R, Hore S, Sen S, Maity S, Ghosh P. Pulse therapy: Opening new vistas in treatment of pemphigus. J Family Med Prim Care [Internet]. 2019;8(3):793\u20138. Available from: https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_114_19","DOI":"10.4103\/jfmpc.jfmpc_114_19"},{"key":"3916_CR9","doi-asserted-by":"publisher","unstructured":"McGee DC. Steroid use during pregnancy. J Perinat Neonatal Nurs [Internet]. 2002;16(2):26\u201339. Available from: https:\/\/doi.org\/10.1097\/00005237-200209000-00004","DOI":"10.1097\/00005237-200209000-00004"},{"key":"3916_CR10","doi-asserted-by":"publisher","unstructured":"Sato H, Asami Y, Shiro R, Aoki M, Yasuda M, Imai S et al. Steroid pulse therapy for DE Novo minimal change disease during pregnancy. Am J Case Rep [Internet]. 2017;18:418\u201321. Available from: https:\/\/doi.org\/10.12659\/ajcr.902910","DOI":"10.12659\/ajcr.902910"},{"key":"3916_CR11","doi-asserted-by":"publisher","unstructured":"Kemp MW, Newnham JP, Challis JG, Jobe AH, Stock SJ. The clinical use of corticosteroids in pregnancy. Hum Reprod Update [Internet]. 2015;dmv047. Available from: https:\/\/doi.org\/10.1093\/humupd\/dmv047","DOI":"10.1093\/humupd\/dmv047"},{"key":"3916_CR12","doi-asserted-by":"publisher","unstructured":"Hari P, Srivastava RN. Pulse corticosteroid therapy with methylprednisolone or dexamethasone. Indian J Pediatr [Internet]. 1998;65(4):557\u201360. Available from: https:\/\/doi.org\/10.1007\/BF02730894","DOI":"10.1007\/BF02730894"},{"key":"3916_CR13","doi-asserted-by":"crossref","unstructured":"Yamanaka E, Ohguro N, Yamamoto S, Nakagawa Y, Imoto Y, Tano Y. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography. Am J Ophthalmol [Internet]. 2002;134(3):454\u20136. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939402015751","DOI":"10.1016\/S0002-9394(02)01575-1"},{"key":"3916_CR14","doi-asserted-by":"publisher","unstructured":"Rahman N, Artiaga JCM, Bouras K, Luis J, Rees A, Westcott M. Immunosuppressive therapy for Vogt\u2013Koyanagi\u2013Harada disease: a retrospective study and review of literature. J Ophthalmic Inflamm Infect [Internet]. 2023;13(1). Available from: https:\/\/doi.org\/10.1186\/s12348-023-00333-6","DOI":"10.1186\/s12348-023-00333-6"},{"key":"3916_CR15","doi-asserted-by":"publisher","unstructured":"Mariotti V, Marconi AM, Pardi G. Undesired effects of steroids during pregnancy. J Matern Fetal Neonatal Med [Internet]. 2004;16:5\u20137. Available from: https:\/\/doi.org\/10.1080\/14767050410001727099","DOI":"10.1080\/14767050410001727099"},{"key":"3916_CR16","doi-asserted-by":"publisher","unstructured":"Ninan K, Liyanage SK, Murphy KE, Asztalos EV, McDonald SD. Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: A systematic review and meta-analysis. JAMA Pediatr [Internet]. 2022;176(6):e220483. Available from: https:\/\/doi.org\/10.1001\/jamapediatrics.2022.0483","DOI":"10.1001\/jamapediatrics.2022.0483"},{"key":"3916_CR17","doi-asserted-by":"publisher","unstructured":"Bandoli G, Palmsten K, Forbess Smith CJ, Chambers CD. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am [Internet]. 2017;43(3):489\u2013502. Available from: https:\/\/doi.org\/10.1016\/j.rdc.2017.04.013","DOI":"10.1016\/j.rdc.2017.04.013"},{"key":"3916_CR18","doi-asserted-by":"publisher","unstructured":"Cai E, Czuzoj-Shulman N, Abenhaim HA. Maternal and fetal outcomes in pregnancies with long-term corticosteroid use. J Matern Fetal Neonatal Med [Internet]. 2021;34(11):1797\u2013804. Available from: https:\/\/doi.org\/10.1080\/14767058.2019.1649392","DOI":"10.1080\/14767058.2019.1649392"},{"key":"3916_CR19","doi-asserted-by":"publisher","unstructured":"R\u00e4ikk\u00f6nen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA [Internet]. 2020;323(19):1924\u201333. Available from: https:\/\/doi.org\/10.1001\/jama.2020.3937","DOI":"10.1001\/jama.2020.3937"},{"key":"3916_CR20","doi-asserted-by":"publisher","unstructured":"Matsuo T, Takahashi K, Kondo T. Vogt-Koyanagi\u2010Harada disease in pregnancy: Case report and review of 32 patients in the literature. Clin Case Rep [Internet]. 2024;12(3). Available from: https:\/\/doi.org\/10.1002\/ccr3.8643","DOI":"10.1002\/ccr3.8643"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03916-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03916-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03916-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T09:20:08Z","timestamp":1752657608000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03916-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3916"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03916-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"366"}}